EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Individual Alpha Frequency as an EEG Biomarker of Drug‐Related Cognitive Burden in Epilepsy

G Assenza iD, B M Sancetta iD, G Lippa, M Nesta, L Ricci iD, C Liguori iD, G Testone, M Fernandes, G Di Mauro, V Di Lazzaro, M Tombini

European Journal of Neurology · 2025-11 · 32 (11)

DOI: 10.1111/ene.70423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 26.11.2025. Verfasst von G Assenza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Neurology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy. Hauptthemen laut MEDLINE: Epilepsy, Anticonvulsants, Cognitive Dysfunction, Alpha Rhythm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Angelini Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

EEG alpha rhythm is well‐proven to correlate with cognitive performance in healthy subjects. We aimed to evaluate the potential of EEG background activity, quantified as individual alpha frequency (IAF), as a biomarker of cognitive impairment induced by antiseizure medications (ASMs) in people with epilepsy (PwE).

Methods

We conducted a cross‐sectional study (S1) and a prospective longitudinal study (S2). In S1, PwE underwent EEG recording and concurrent EpiTrack assessment. In S2, EEG and EpiTrack were performed before and 6 months after initiating cenobamate. Correlation analyses assessed the association between EpiTrack scores and IAF (S1) and their changes post‐cenobamate (S2). ANOVA and ANCOVA were used to compare IAF between cognitively impaired and unimpaired PwE. Logistic regression evaluated the incremental value of IAF combined with clinical variables to identify cognitive improvement following ASM modification.

Results

We enrolled 100 PwE (42 ± 18 years) in S1 and 33 PwE (45 ± 15 years) in S2. IAF correlated significantly with EpiTrack scores in S1 ( R = 0.21, p = 0.03), and IAF changes mirrored EpiTrack improvements post‐cenobamate in S2 ( R = 0.34, p = 0.04). Cognitively impaired PwE displayed significantly lower IAF independent of age, seizure frequency, epileptiform activity, and pharmacological load ( p = 0.01–0.005). Adding IAF to clinical variables significantly improved the logistic model's accuracy in predicting cognitive improvement post‐treatment (AUC: 0.83 ± 0.04 vs. 0.71 ± 0.04, p = 0.005).

Conclusions

EEG background activity, assessed via IAF, is sensitive to cognitive impairment related to ASMs in PwE, demonstrated in both cross‐sectional and longitudinal contexts. IAF is thus a promising, simple, cost‐effective biomarker to monitor cognitive burden in clinical epilepsy management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnticonvulsantsCognitive DysfunctionAlpha RhythmHumansMaleFemaleAdultMiddle AgedCross-Sectional StudiesElectroencephalographyLongitudinal StudiesBiomarkersProspective Studies

Stichwörter der Autor:innen

EEGEpiTrackcognitive burdenepilepsyindividual alpha frequency

Substanzen

AnticonvulsantsBiomarkers

Autor:innen und Institutionen

  • Research Unit of Neurology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Operative Research Unit of Neurology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.
  • Epilepsy Centre, Neurology Unit, University Hospital of Rome tor Vergata, Rome, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

ORCID-Profile: G Assenza, B M Sancetta, L Ricci, C Liguori

Förderung

  • Angelini Pharma

Zitieren

APA

Assenza, G., Sancetta, B. M., Lippa, G., Nesta, M., Ricci, L., Liguori, C., Testone, G., Fernandes, M., Di Mauro, G., Di Lazzaro, V., & Tombini, M. (2025). Individual Alpha Frequency as an EEG Biomarker of Drug‐Related Cognitive Burden in Epilepsy. European Journal of Neurology, 32(11). https://doi.org/10.1111/ene.70423

Vancouver

Assenza G, Sancetta BM, Lippa G, Nesta M, Ricci L, Liguori C, et al. Individual Alpha Frequency as an EEG Biomarker of Drug‐Related Cognitive Burden in Epilepsy. European Journal of Neurology. 2025;32(11). doi:10.1111/ene.70423

BibTeX
@article{Assenza2025,
  author = {Assenza, G and Sancetta, B M and Lippa, G and Nesta, M and Ricci, L and Liguori, C and Testone, G and Fernandes, M and Di Mauro, G and Di Lazzaro, V and Tombini, M},
  title = {Individual Alpha Frequency as an EEG Biomarker of Drug‐Related Cognitive Burden in Epilepsy},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {11},
  doi = {10.1111/ene.70423}
}
Kostenlos starten →